- All
- Event Participitation (4)
- News & Press releases (4)
- Scientific Publication (2)
News & Press releases
Cycuria Therapeutics Announces the Formation of a Distinguished Advisory Board and Significant Public Grant Funding from FFG and AWS
📢 We’re proud to unveil exciting news from Cycuria Therapeutics. We’ve secured grant funding from two leading Austrian national bodies, FFG and AWS, and today...
Event Participitation
Cycuria to Present at the Startup Spotlight at BIO-Europe Spring
Cycuria has been selected to present at the Startup Spotlight Stage during the upcoming BIO-Europe Spring partnering conference! Our presentation will showcase Cycuria’s pioneering approach...
News & Press releases
Cycuria Wins the SPIRIT Startup Award 2025 in the Health Category
We are thrilled to announce that Cycuria has been honored with the SPIRIT Startup Award in the Health category ! This prestigious recognition highlights our...
Event Participitation
Meet Cycuria at ASH Annual Meeting 2024 in San Diego
Cycuria will be attending the upcoming American Society of Hematology (ASH) Annual Meeting in San Diego from December 7- December 10. We look forward to...
News & Press releases
Cycuria Founder, Prof. Dr. Philipp Jost, Highlights the Strategic Advantages and Opportunities at Medical Science City Graz
We’re thrilled to share recent press coverage highlighting Cycuria Therapeutics‘ innovative approach in oncology and our choice to establish roots in Graz’s Medical Science City,...
News & Press releases
Cycuria Featured in the Austrian National Newspaper Die Presse
Die Presse, one of Austria’s most respected national newspapers, features our scientific breakthrough in cancer research led by our scientific founder, Prof. Dr. Philipp Jost....